Xenon Pharmaceuticals (XENE) Payables: 2013-2025
Historic Payables for Xenon Pharmaceuticals (XENE) over the last 11 years, with Sep 2025 value amounting to $36.8 million.
- Xenon Pharmaceuticals' Payables rose 30.14% to $36.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.3 million, marking a year-over-year increase of 26.81%. This contributed to the annual value of $34.2 million for FY2024, which is 31.75% up from last year.
- As of Q3 2025, Xenon Pharmaceuticals' Payables stood at $36.8 million, which was up 16.63% from $31.6 million recorded in Q2 2025.
- In the past 5 years, Xenon Pharmaceuticals' Payables registered a high of $36.8 million during Q3 2025, and its lowest value of $7.6 million during Q1 2021.
- Its 3-year average for Payables is $28.2 million, with a median of $28.3 million in 2024.
- In the last 5 years, Xenon Pharmaceuticals' Payables fell by 6.23% in 2021 and then spiked by 166.81% in 2023.
- Over the past 5 years, Xenon Pharmaceuticals' Payables (Quarterly) stood at $13.7 million in 2021, then skyrocketed by 61.95% to $22.2 million in 2022, then climbed by 16.93% to $26.0 million in 2023, then soared by 31.75% to $34.2 million in 2024, then skyrocketed by 30.14% to $36.8 million in 2025.
- Its Payables was $36.8 million in Q3 2025, compared to $31.6 million in Q2 2025 and $30.6 million in Q1 2025.